SCHEMBL4941135

SCHEMBL4941135

CN(C)c1ccc2nc3ccccc3[s+]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.48
TERT O14746 1/20 0.48
PSMB5 P28074 3/20 0.42
APAF1 O14727 1/20 0.41
KDM1A O60341 8/20 0.41
SLC2A1 P11166 1/20 0.40
EGFR P00533 2/20 0.40
ALDH1A1 P00352 2/20 0.38
GLA P06280 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
ACHE P22303 1/20 0.38
CYP1A2 P05177 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4941549 0.98 APP (0.47) APPTERTPSMB5APAF1KDM1A
Iodide SCHEMBL4941552 0.97 APP (0.46) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL128584 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL109755 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL12312497 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL12312498 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL12312491 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL29941578 0.91 APP (0.57) APPTERTPSMB5APAF1KDM1A
Methylene Blue Cation SCHEMBL1351 0.89 APP (0.55) APPTERTPSMB5APAF1EGFR
Methylene Blue Cation SCHEMBL4565666 0.89 APP (0.55) APPTERTPSMB5APAF1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7344823-B2 Transient optical state change materials useful in copy-protected compact discs VERIFICATION TECHNOLOGIES, INC. (US) 2008-03-18 US claimed
US-7344823-B2 Transient optical state change materials useful in copy-protected compact discs VERIFICATION TECHNOLOGIES, INC. (US) 2008-03-18 US disclosed
US-20080062838-A1 MATERIALS FOR OPTICAL MEDIUM COPY-PROTECTION TRANSIENTLY REACTING TO A READER BEAM VERIFICATION TECHNOLOGIES, INC. (US) 2008-03-13 US disclosed
US-20040121262-A1 Transient optical state change materials useful in copy-protected compact discs SPENCER TRASK HEALTHCARE VENTURES LLC 2004-06-24 US disclosed
US-20040004922-A1 Materials for optical medium copy-protection transiently reacting to a reader beam VERIFICATION TECHNOLOGIES, INC. 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040121262-A1 Transient optical state change materials useful in copy-protected compact discs RAD51, VCL, TRRAP APP 1232/4885TERT 68/4885PSMB5 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.